Italian court upholds Aspen excessive pricing decision

Janith Aranze

03 August 2017

Italian court upholds Aspen excessive pricing decision

istock/luchschen

An Italian court has upheld the Italian Antitrust Authority's decision to fine pharmaceutical company Aspen €5 million for abuse of dominance, backing the enforcer's benchmark for assessing whether the company had unfairly inflated the prices of cancer drugs.